Experimental approach for optimizing dose regimen of 68Ga-DOTATATE PET/CT for neuroendocrine tumor (NET) imaging in current high sensitivity scanners: Phantom and Patient Study.

Abstract

This study aimed to determine the optimized scan time and injected activity regimen for clinical ⁶⁸Ga DOTATATE PET/CT in neuroendocrine tumor imaging through an experimental approach without using machine learning techniques.A NEMA PET body phantom was used with Ga-⁶⁸ to simulate a 9:1 sphere-to-background ratio. PET data were acquired on a high-sensitivity scanner at various scan times (15-300 s/bed). For each scan time, coefficient of variation (COV) and contrast-to-noise ratio (CNR) were calculated. The minimum scan time (T_min) needed to meet the Rose Criterion (CNR > 5) for the smallest sphere was identified. This T_min was then applied to patient scans with neuroendocrine tumors (originally acquired at 120 s/bed) to evaluate image quality and determine an optimized activity regimen for clinical ⁶⁸Ga-DOTATATE PET imaging.Phantom experiments showed that a COV_max of 20% is the highest acceptable noise level for detecting the smallest lesions, corresponding to a minimum scan time of about 1 minute per bed position. Patient image analysis confirmed that all tumors visible at routine scan times were still detectable at this minimum duration. This supports the use of a lower activity regimen (~1 MBq/kg), which can reduce patient radiation exposure compared to the standard 1.85 MBq/kg protocol.This work demonstrated that scan time and activity for ⁶⁸Ga-DOTATATE NET imaging can be significantly minimized without compromising image interpretation and quantification.